Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
EPA CPDat observed this chemical in 3213 composition records across product categories including Furniture and furnishings, Construction and building materials, Laboratory supplies.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 · limited confidence.
Prevalence of SULFURIC ACID in our catalog (epa_cpdat).
Products
3,213
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 3213 composition records across product categories including Furniture and furnishings, Construction and building materials, Laboratory supplies. EPA CPDat classifies this chemical for functional uses including pH regulating agent, Fragrance, No specific technical function.
US
FDA
Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: 0.02 %w/v
US
FDA
Route: ENDOTRACHEAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: EPIDURAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: EPIDURAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 566 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 315 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRAPERITONEAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRATHECAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRATHECAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 566 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 315 mg
US
FDA
Route: INTRAVENOUS; Dosage form: SOLUTION; Potency: ADJ PH
US
FDA
Route: IRRIGATION; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: IRRIGATION; Dosage form: SOLUTION; Potency: ADJ PH
US
FDA
Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 8 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 0.02 %w/w
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: ADJ PH
US
FDA
Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: ADJ PH
US
FDA
Route: PARENTERAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: CAPSULE; Maximum daily exposure: 78 mg
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: SOLUTION; Maximum daily exposure: 150 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 2 mg
US
FDA
FDA NDC lists this ingredient in 61 active drug products and 66 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.